Cargando…
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice
Exendin-4 (Ex-4), a glucagon-like peptide-1 receptor (GLP-1R) agonist, has been known to reverse hepatic steatosis in ob/ob mice. Although many studies have evaluated molecular targets of Ex-4, its mechanism of action on hepatic steatosis and fibrosis has not fully been determined. In the liver, glu...
Autores principales: | Kim, Seok, Jung, Jaehoon, Kim, Hwajin, Heo, Rok Won, Yi, Chin-ok, Lee, Jung Eun, Jeon, Byeong Tak, Kim, Won-Ho, Hahm, Jong Ryeal, Roh, Gu Seob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146636/ https://www.ncbi.nlm.nih.gov/pubmed/25177166 http://dx.doi.org/10.4196/kjpp.2014.18.4.333 |
Ejemplares similares
-
Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
por: Kim, Kyung Eun, et al.
Publicado: (2023) -
Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice
por: Choi, Ha-Neul, et al.
Publicado: (2014) -
Altered Hepatic Lipid Metabolism Contributes to Nonalcoholic Fatty Liver Disease in Leptin-Deficient Ob/Ob Mice
por: Perfield, James W., et al.
Publicado: (2013) -
Skeletal Lipocalin-2 Is Associated with Iron-Related Oxidative Stress in ob/ob Mice with Sarcopenia
por: Choi, Eun Bee, et al.
Publicado: (2021) -
Early Sensorineural Hearing Loss in Ob/Ob Mouse, an Animal Model of Type 2 Diabetes
por: Lee, Hyun-Seok, et al.
Publicado: (2008)